09/08/2014 - 9:32am

The number of uninsured is expected to decline by nearly half from 45 million in 2012 to 23 million by 2023 as a result of the coverage expansions associated with the Affordable Care Act.

09/05/2014 - 10:29am

Mylan on Friday announced that it has launched a generic version of Hoffmann-La Roche's Boniva injection.

09/05/2014 - 9:57am

Walgreens is offering more than $10 million worth of flu shot vouchers free to those without health insurance coverage.

 

09/04/2014 - 10:33am

Teva Pharmaceutical on Thursday announced the launch of generic Baraclude (entecavir) tablets in 0.5-mg and 1-mg dosage strengths. The company was the first to file, giving it 180 days of marketing exclusivity for the drug. 

09/04/2014 - 8:46am

The Drug Enforcement Administration National Prescription Drug Take-Back Day collection site locator is now available online, the National Association of Boards of Pharmacy reported Wednesday.

09/04/2014 - 5:50am

New research suggests that sleeping seven to eight hours per night is associated with the lowest risk of absence from work due to sickness, the National Healthy Sleep Awareness Project reported Wednesday.

09/03/2014 - 9:30am

Teva Pharmaceutical on Wednesday announced that a positive judgment has been given by the U.K. High Court in support of Teva's case against AstraZeneca relating to the validity of EP 1,085,877 covering the SMART (Single inhaler Maintenance And Reliever Therapy) indication for AstraZeneca's fixed dose formoterol/budesonide combination product, Symbicort.

09/03/2014 - 6:21am

The National Institutes of Health has issued a final NIH Genomic Data Sharing policy to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while protecting the privacy of research participants. 

09/02/2014 - 11:15am

Among patients with hypertension at high risk of cardiovascular disease, a program where patients measured their blood pressure and adjusted their antihypertensive medication accordingly resulted in lower systolic blood pressure at 12 months compared with patients who received usual care, according to a study in the Aug. 27 issue of JAMA.